A Phase II Study of Neoadjuvant Chemotherapy With and Without Trastuzumab in Patients With Breast Cancer
Phase of Trial: Phase II
Latest Information Update: 31 Oct 2017
At a glance
- Drugs Trastuzumab (Primary) ; Cyclophosphamide; Doxorubicin; Paclitaxel
- Indications Advanced breast cancer; Breast cancer
- Focus Adverse reactions; Pharmacogenomic; Therapeutic Use
- 31 Oct 2017 Last checked against ClinicalTrials.gov record
- 24 Oct 2017 Planned End Date changed from 1 Dec 2017 to 1 Dec 2019.
- 24 Oct 2017 Planned primary completion date changed from 1 Dec 2017 to 1 Dec 2018.